Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research • 13 hours ago

How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?

HOLX's $18.3B Blackstone-TPG buyout nears close after Q1 miss. With shares near a $76 cash offer, the upside for HOLX investors looks dim.

Zacks Investment Research • Feb 16, 2026

Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Investment Research • Feb 13, 2026

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #FDA--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio.

Business Wire • Feb 4, 2026

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research • Feb 2, 2026

Hologic (HOLX) International Revenue Performance Explored

Review Hologic's (HOLX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks Investment Research • Feb 2, 2026

HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash

Hologic slips after a Q1 EPS and revenue miss, as gross margin fell 150 bps with Diagnostics weakness offset by strong GYN Surgical growth.

Zacks Investment Research • Jan 30, 2026

Hologic Announces Financial Results for First Quarter of Fiscal 2026

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for First Quarter of Fiscal 2026.

Business Wire • Jan 29, 2026

Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates

Hologic (HOLX) came out with quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.03 per share a year ago.

Zacks Investment Research • Jan 29, 2026

Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics

The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Jan 30, 2026